Doctors demand arrest of those involved in recent attacks on two physicians in the district
Russia began mass trials of EpiVacCorona, which is being developed by Siberia's Vector Institute, in November.
Moscow has said its other approved COVID-19 vaccine, Sputnik V, is 92% effective at protecting people from COVID-19 according to interim results.